We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$227M
AUM Growth
-$6.87M
(-2.9%)
Cap. Flow
-$1.96M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
27.69%
Holding
114
New
9
Increased
33
Reduced
56
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$6.51M |
| 2 |
Blackrock
BLK
|
+$6.46M |
| 3 |
Viatris
VTRS
|
+$4.57M |
| 4 |
Whirlpool
WHR
|
+$3.53M |
| 5 |
Best Buy
BBY
|
+$3.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$8.27M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$5.65M |
| 3 |
Lockheed Martin
LMT
|
+$5.61M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$5.58M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.14% |
| 2 | Technology | 16.57% |
| 3 | Financials | 16.01% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Consumer Staples | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
AbbVie
ABBV
$435B
| – | – |
-61,063
| Closed | -$8.27M |
|
|
102
Bristol-Myers Squibb
BMY
$132B
| – | – |
-90,553
| Closed | -$5.65M |
|
103
Costco
COST
$420B
| – | – |
-928
| Closed | -$527K |
|
104
Cisco
CSCO
$479B
| – | – |
-3,243
| Closed | -$206K |
|
105
Quest Diagnostics
DGX
$26.3B
| – | – |
-1,244
| Closed | -$215K |
|
|
HTBK
106
DELISTED
Heritage Commerce
HTBK
| – | – |
-20,562
| Closed | -$246K |
|
|
107
Lockheed Martin
LMT
$136B
| – | – |
-15,788
| Closed | -$5.61M |
|
108
Quanta Services
PWR
$101B
| – | – |
-2,891
| Closed | -$331K |
|
109
Schwab U.S Small- Cap ETF
SCHA
$23.1B
| – | – |
-8,436
| Closed | -$216K |
|
110
Schwab US Mid-Cap ETF
SCHM
$15.1B
| – | – |
-7,560
| Closed | -$203K |
|
111
Upbound Group
UPBD
$1.16B
| – | – |
-5,623
| Closed | -$270K |
|
|
WBA
112
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-68,590
| Closed | -$3.58M |
|
|
XLNX
113
DELISTED
Xilinx Inc
XLNX
| – | – |
-13,129
| Closed | -$2.78M |
|
|
STL
114
DELISTED
Sterling Bancorp
STL
| – | – |
-8,543
| Closed | -$220K |
|
Similar funds
PCC
CF
SGCM
RCWM
LCA
FPWM
SMF
RFS
Palouse Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Palouse Capital Management held 114 positions worth $227M, down 2.9% from $234M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Palouse Capital Management's Q1 2022 filing shows 9 new, 33 increased, 56 reduced and 14 closed positions. Its largest new stake was Blackrock: 8,267 shares worth $6.32M. The largest sale was AbbVie, an estimated $8.27M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
- Palouse Capital Management's largest Q1 2022 buy was Blackrock: 8,267 shares worth $6.32M.
- Palouse Capital Management added most to Vanguard Intermediate-Term Corporate Bond ETF in Q1 2022, an estimated $6.51M increase.
- Palouse Capital Management's biggest Q1 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $5.58M.
- Palouse Capital Management fully exited AbbVie in Q1 2022, selling an estimated $8.27M.
- Palouse Capital Management's ten largest holdings make up 28% of its $227M portfolio in Q1 2022.
- Palouse Capital Management opened 9 new positions and closed 14 in Q1 2022.
- Palouse Capital Management's portfolio value fell 2.9% quarter-over-quarter to $227M.
Based on Palouse Capital Management's 13F filing for Q1 2022, filed 21 Apr 2022.